Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals

Current Medical Research and Opinion

Volumn 27, Issue 10, 2011, Pages 2043-2052

  Bailey, T ^a   Thurman, J ^b   Niemeyer, M ^c   Schmeisl, G ^d  

^a AMCR Institute Inc   (United States)

^b SSM Saint Charles Medical Group   (United States)

^c NOVO NORDISK A S   (Denmark)

^d Deegenbergklinik ^*  (Germany)

Author keywords

Confidence; Diabetes patients; Healthcare professionals; Preference; Prefilled insulin pen; Usability

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; FLEXTOUCH; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERVIEW; KWIKPEN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; OUTCOME ASSESSMENT; PHYSICIAN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRADERMAL; INSULIN; MALE; MIDDLE AGED; NURSES; PHYSICIANS; QUESTIONNAIRES;

EID: 80053001911     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.616190     Document Type: Article

References (40)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
2. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:293-301
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53
5. Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a prefilled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-7
6. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74 (Pubitemid 38112268)
7. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40 (Pubitemid 29028310)
8. Glasgow RE, Fisher EB, Anderson BJ, et al. Behavioral science in diabetes. Contributions and opportunities. Diabetes Care 1999;22:832-43 (Pubitemid 29220789)
9. Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28: 2673-9 (Pubitemid 43951158)
10. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26: 1498-505 (Pubitemid 39572159)
11. Thurman JE. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007;13:672-8
12. Sommavilla B, Jorgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2223-32
13. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7 (Pubitemid 39281409)
14. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997;20: 292-8 (Pubitemid 27098212)
15. Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 2010;33:733-5
16. Mollema ED, Snoek FJ, Heine RJ, et al. Phobia of self-injecting and selftesting in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18:671-4 (Pubitemid 32823067)
17. Peyrot M, Mathews DR, Snoek FJ, et al. An international study of psychological resistance to insulin use among persons with diabetes. Diabetologia 2003;46(Suppl 2):A89
18. Zambanini A, Newson RB, Maisey M, et al. Injection related anxiety in insulintreated diabetes. Diabetes Res Clin Pract 1999;46:239-46
19. Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121:S35-41 (Pubitemid 351726337)
20. Olsen BS, Lilleøre SK, Korsholm CN, et al. NovoPen Echo for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents and health care professionals. J Diabetes Sci Tech 2010;4:1468-75
21. Pfützner J, Hellhammer J, Musholt P, et al. Evaluation of dexterity in insulintreated patients with type 1 and type 2 diabetes mellitus. J Diabetes Sci Technol 2011;5:158-65
22. Asakura T, Jensen KH. Comparison of intuitiveness, ease of use, and preference in two insulin pens. J Diabetes Sci Technol 2009;3:312-19
23. Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4:522-31
24. Bastian MD, Wolters NE, Bright DR. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes. Consult Pharm 2011;26:426-9
25. Hemmingsen H, Niemeyer M, Hansen MR, et al. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011; doi: 10.1089/dia.2011.0110. [Epub ahead of print]
26. Pfützner A, Reimer T, Frokjaer LPF, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-9
27. Savas S, Köroglu BK, Koyuncuog? lu HR, et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83 (Pubitemid 46590476)
28. Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-32 (Pubitemid 28241436)
29. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;10(Suppl 2):82S-6S (Pubitemid 23162713)
30. Wielandt JO, Niemeyer M, Hansen MR, et al. FlexTouch : a prefilled insulin pen with a novel injection mechanism with consistent, high accuracy at low (1 IU), medium (40 IU) and high (80 IU) dose settings. J Diabetes Sci Tech 2011;5:1195-9
31. Peyrot M, Rubin RR. Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes. Diabetes Tech Therapeut 2011;13:43-8
32. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
33. Faurie C, Raymond M. Handedness frequency over more than ten thousand years. Proc Biol Sci 2004;271(Suppl 3):S43-5 (Pubitemid 38186905)
34. Buus P, Lilleøre SK, Larsen K. Compatibility testing of two types of pen needles with a range of injection pens for diabetes medication. Curr Med Res Opin 2011;27:589-92
35. Niskanen L, Jensen LE, Rastam J, et al. Randomized, multinational, openlabel, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-40 (Pubitemid 38586454)
36. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin 1945;1:80-3
37. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947;12:153-7
38. Brod M, Kongso JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18: 23-32
39. Clark PE, Valentine V, Bodie JN, et al. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin 2010;26:1745-53
40. Musholt P, Schipper C, Niemeyer M, et al. Self-assessment and determination of dexterity and cognitive function in patients with type 1 and type 2 diabetes mellitus [abstract] No 2222-PO. American Diabetes Association 71st Scientific Sessions. Diabetes 2011;60(Suppl 1)